Actavis announced that it has received approval from the FDA to market Mixed Amphetamine Salts ER (dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate extended-release) capsules, the generic version of Shire‘s Adderall XR capsules.
Adderall XR is a Class II amphetamine indicated for attention deficit hyperactivity disorder (ADHD). These agents block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extraneuronal space.
Mixed Amphetamine Salts ER capsules are currently available from Actavis in 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg dosage strengths in 100-count bottles.
For more information call (973) 993-4500 or visit www.actavis.us.